Synchron · 3 months ago
IT Helpdesk Support Analyst - NAVSEA
Synchron, LLC has an exciting opportunity for an IT Helpdesk Support Analyst to support NAVSEA at the Washington Navy Yard in Washington, DC. The role involves providing excellent technology customer service support to the US Navy, performing Tier I problem resolution services, and enhancing overall service delivery through effective technical solutions.
Information TechnologyManufacturingMedicalMedical Device
Responsibilities
Support customer facing troubleshooting activities and problem escalation, via in-person and some remote support
Operate in a routine shift-work environment
Provide effective technical solution to complex problems to include Tier I trouble shooting of ServiceNow incidents or problems when requested
Provide emerging communications and information technology engineering support and technical solutions to improve overall service delivery to include customer support, proactive system support ect
Develop SOPs and define processes to enhance Customer Support and IT Service Delivery
Support the customer’s efforts to share and distribute information by electronic means
Qualification
Required
Active Secret Clearance
Security+ Certification
2 years of experience providing IT support to the DoD and/or Navy
Purebred Agent Experience
Managing Service Desk and Customer facing support experience
Excellent communication skills
Positive customer service attitude and professional etiquette
Ability to prioritize and handle multiple projects/stakeholders
Preferred
Customer support experience in enterprise user service and help desk incident management within the DoD or Navy
Experience and knowledge working with NMCI and Flank Speed on both NIPR and SIPR networks
Customer support experience/knowledge working in FastTool, Archibus, TIE Coordination, Mobility, VTC, Microsoft Azure, Asset Management and Process/SOP documentation
Company
Synchron
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Funding
Current Stage
Late StageTotal Funding
$330MKey Investors
Double Point VenturesARCH Venture PartnersMax Hodak
2025-11-06Series D· $200M
2022-12-15Series C· $75M
2022-02-04Series Unknown
Recent News
Startup Daily
2025-12-24
Company data provided by crunchbase